Edit |   |
---|---|
Antigenic Specificity | VWF A1 domain, Human (Caplacizumab biosimilar) |
Clone | Caplacizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | VH-VH |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human VWF A1 domain Recombinant Antibody. Caplacizumab (INN, trade name Cablivi) is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis. |
Immunogen | n/a |
Other Names | Anti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab, Anti-Human VWF A1 domain Recombinant Antibody, ALX-0081, PMP12A2h1-linker AAA-PMP12A2h1, Antibody Drug Analogues, Monoclonal Antibody, YR1265, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 915810-67-2 |
Catalog # | YR1265 |
Price | please inquire |
Order / More Info | VWF A1 domain, Human (Caplacizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |